Cellectar Biosciences (CLRB) Reports Q1 Loss of $0.30/Share

Cellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of ($0.30), versus ($1.03) reported last year.

For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c
• Evolution Petroleum launches stock offering to fund Permian Basin deal